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Oxidized proteins  
and podocyte loss
Many extracellular proteins that are 
long lived become oxidized, and there is 
increasing evidence that these proteins 
can be pathogenic. As they report in 
this issue, Zhou et al. infused rats with 
oxidized albumin and found that there 
was an increase in apoptosis of podo-
cytes. In addition, there was increas-
ing proteinuria that preceded the loss 
of podocytes. In an effort to study the 
cellular mechanism of this effect, the 
authors found that podocytes cultured 
in vitro and exposed to the oxidized 
albumin caused the production of 
superoxide by activation of NADPH 
oxidases. Inhibition of these enzymes 
in vitro and in vivo protected the 
podocytes from the apoptosis induced 
by oxidized albumin. These studies 
demonstrate that oxidative damage to 
podocytes can be induced by oxidized 
proteins. See page 1148.
Impact of randomized 
controlled trials on 
physician behavior
Randomized controlled trials are the 
gold standard for evidence for the util-
ity, or lack of it, of any drug. The ques-
tion remains whether these trials have 
an impact on the behavior of physi-
cians. Lam et al. attempted to answer 
this question by examining whether 
physicians continued to prescribe stat-
ins to diabetics on hemodialysis even 
though a well-conducted trial showed 
that there was no benefit in this popu-
lation. They looked at the prescription 
behavior of Canadian physicians in a 
retrospective analysis comparing peri-
ods before the appearance of the results 
of the trial with those after. Statin use 
actually continued to rise rather than 
decline after the publication. What is 
the reason? The authors discuss this 
issue without coming to a specific con-
clusion. There is concern that with such 
overwhelming evidence that statins 
reduce cardiovascular mortality and 
morbidity in unselected populations, 
physicians may to discount studies 
that show no benefit in highly selected 
populations. See page 1172.
Medication errors 
in renal failure in 
community hospitals
Medication errors are attracting the 
attention of regulators and physicians 
alike. There is nothing more embarrass-
ing to the profession than the unnec-
essary burden imposed by such errors 
on patients already suffering from their 
disease. Many such studies are con-
ducted in academic institutions, but 
Hug et al. studied community hospitals 
to examine the incidence and severity 
of adverse drug events in patients with 
reduced creatinine clearance. Review-
ing the charts of patients with serum 
creatinine levels higher than 1.5 mg/
dl who were exposed to drugs that are 
nephrotoxic or cleared by the kidney, 
they found in a random sample that 
almost half had potential and 10% had 
possible adverse drug events. Most of 
these adverse events were preventable, 
and some were even life-threatening. 
The depressing news is that most of 
the preventable events could have been 
intercepted by appropriate corrections 
for the dose of the drug in renal failure. 
See page 1192.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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